Trials / Unknown
UnknownNCT03334110
A Clinical Randomized Controlled Trial of the New Method of Selective Coronary Vein Bypass Graft (SCVBG)
Clinical Randomized Controlled Trial of the New Method of Selective Coronary Venous Bypass Graft on Improving Curative Effects in Patients With Diffuse Coronary Artery Disease
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 320 (estimated)
- Sponsor
- Beijing Anzhen Hospital · Academic / Other
- Sex
- All
- Age
- 70 Years
- Healthy volunteers
- Not accepted
Summary
Apply a new operation method of Left Internal Mammary Artery (LIMA)-Greater Saphenous Vein (GSV)-SCVBG to the treatment of patients with diffuse coronary artery disease,through clinical randomized controlled study,compared with patients of bilateral internal mammary artery (BIMA)-SCVBG and evaluate both of therapeutic effects and prognosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | A method of operation: LIMA-GSV-SCVBG | On the experimental group,We treat patients with the operation of LIMA-GSV composited Y graft and anastomose the GSV with selective coronary vein |
| PROCEDURE | BIMA-SCVBG | On the other group, We treat patients with the operation of bilateral internal mammary artery composited LIMA-Right Mammary Artery（RIMA） y graft and anastomose the Right Mammary Artery(RIMA) with selective coronary vein. |
Timeline
- Start date
- 2017-11-30
- Primary completion
- 2017-12-01
- Completion
- 2018-09-01
- First posted
- 2017-11-07
- Last updated
- 2017-11-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03334110. Inclusion in this directory is not an endorsement.